Loading provider…
Loading provider…
Pediatric Nephrology Physician in Hackensack, NJ
NPI: 1174582951Primary Practice Location
HACKENSACK UNIVERSITY MEDICAL CENTER
30 Prospect Ave, Hackensack, NJ
Primary Employer
Hmhmg Specialty Care
hmhn.org
HQ Phone
Get MD Kenneth's Phone Numberphone_androidMobile
Get MD Kenneth's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNJ State Medical License
NJ State Medical License
2001 - 2027
NY State Medical License
1978 - 2010

American Board of Pediatrics
Pediatric Nephrology

American Board of Pediatrics
Pediatrics
New York Presbyterian Hospital (Cornell Campus)
Fellowship • Pediatric Nephrology
1979 - 1981
Icahn School of Medicine at Mount Sinai/Kravis Children's
Residency • Pediatrics
1977 - 1979
Albert Einstein College of Medicine
einsteinmed.edu
Medical School
Until 1977
Princeton University
BSE • Computer Science
1969 - 1973
DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS
Authors: Debbie Gipson, Howard Trachtman, Abanti Chaudhuri, Jai Radhakrishnan, Tarak Srivastava
Journal: J Am Soc Nephrol
Lead Sponsor: AstraZeneca
Intervention / Treatment: DRUG: Sodium Zirconium Cyclosilicate (SZC) Reduced Dose Level, DRUG: Sodium Zirconium Cyclosilicate (SZC) Dose Level 1 (DL1), DRUG: Sodium Zirconium Cyclosilicate (SZC) Dose Level 2 (DL2), DRUG: Sodium Zirconium Cyclosilicate (SZC) Dose Level 3 (DL3), DRUG: Sodium Zirconium Cyclosilicate (SZC) Dose During 28 Day Maintenance Phase
Lead Sponsor: Biogen
Intervention / Treatment: DRUG: Bardoxolone methyl
Lead Sponsor: Travere Therapeutics, Inc.
Intervention / Treatment: DRUG: Irbesartan, DRUG: sparsentan